Oppenheimer & CO Inc Simulations Plus, Inc. Transaction History

Oppenheimer & CO Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$40.03 - $51.51 $69,532 - $89,472	-1,737 Reduced 17.07%	8,439 $351,000
Q2 2023 Aug 02, 2023	SELL	$40.45 - $48.0 $17,433 - $20,688	-431 Reduced 4.06%	10,176 $440,000
Q1 2023 May 10, 2023	SELL	$34.96 - $43.94 $8,740 - $10,985	-250 Reduced 2.3%	10,607 $466,000
Q4 2022 Feb 07, 2023	SELL	$36.55 - $51.15 $25,584 - $35,805	-700 Reduced 6.06%	10,857 $397,000
Q3 2022 Nov 14, 2022	BUY	$47.75 - $66.88 $429 - $601	9 Added 0.08%	11,557 $561,000
Q2 2022 Aug 08, 2022	SELL	$40.55 - $51.76 $892 - $1,138	-22 Reduced 0.19%	11,548 $570,000
Q1 2022 May 12, 2022	BUY	$36.56 - $50.98 $15,720 - $21,921	430 Added 3.86%	11,570 $590,000
Q4 2021 Feb 02, 2022	SELL	$37.1 - $57.45 $26,192 - $40,559	-706 Reduced 5.96%	11,140 $527,000
Q3 2021 Nov 12, 2021	BUY	$38.45 - $55.66 $3,229 - $4,675	84 Added 0.71%	11,846 $468,000
Q2 2021 Aug 03, 2021	BUY	$49.67 - $68.96 $584,218 - $811,107	11,762 New	11,762 $646,000

176

15.2M

5.4K

1.4K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $636M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.